share_log

药明生物(02269)根据受限制股份奖励计划授出合共303.72万股

Pharmaceutical Biology (02269) granted a total of 3,037,200 shares under the restricted share reward scheme

Zhitong Finance ·  11/21/2023 20:53

Pharmaceutical Biology (02269) issued an announcement. On November 21, 2023, the company's board of directors approved the grant...

According to the Zhitong Finance App, Pharmaceutical Biology (02269) issued an announcement. On November 21, 2023, the company's board of directors has approved the grant of a total of 3,037,200 restricted shares of the restricted share reward plan, but it must be accepted by the restricted share reward plan undertakers in accordance with the restricted share reward plan before it can be implemented. The market value of the shares on the date of grant was HK$48.55 per share.

On November 21, 2023, the company's board of directors approved the grant of a total of 7.8894 million restricted shares of the Global Partner Program. This can only be done if the Global Partner Program grantor accepts them in accordance with the Global Partner Share Award Program. The market value of the shares on the date of grant was HK$48.55 per share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment